Onderneming Annexin Pharmaceuticals AB
Aandelen
ANNX
SE0009664154
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,312 SEK | +1,30% | +5,05% | +20,00% |
Vakgebied
Aantal werknemers: 4
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anna Frostegård
FOU | Founder | 51 | 01-01-14 |
Chief Executive Officer | 63 | 01-01-18 | |
Director of Finance/CFO | 53 | 11-04-23 | |
Susan Suchdev
COO | Chief Operating Officer | 52 | - |
Alain Thibault
PRN | Corporate Officer/Principal | - | 18-01-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 01-01-21 |
Mårten Österlund
BRD | Director/Board Member | 67 | 01-01-21 |
Chief Executive Officer | 63 | 01-01-18 | |
Director/Board Member | 48 | 01-01-17 | |
Director/Board Member | 65 | 01-01-16 | |
Director/Board Member | 66 | 01-01-17 | |
Director/Board Member | 71 | - | |
Anthon Jahreskog
BRD | Director/Board Member | 44 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 346 583 688 | 75 900 956 ( 21,90 %) | 0 | 21,90 % |
Bedrijfsgegevens
Sector
Chiffre d''affaires - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,00% | 10,01 mln. | |
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |
- Beurs
- Aandelen
- Koers ANNX
- Onderneming Annexin Pharmaceuticals AB